quinacrine has been researched along with Sulfhemoglobinemia in 1 studies
Quinacrine: An acridine derivative formerly widely used as an antimalarial but superseded by chloroquine in recent years. It has also been used as an anthelmintic and in the treatment of giardiasis and malignant effusions. It is used in cell biological experiments as an inhibitor of phospholipase A2.
quinacrine : A member of the class of acridines that is acridine substituted by a chloro group at position 6, a methoxy group at position 2 and a [5-(diethylamino)pentan-2-yl]nitrilo group at position 9.
Sulfhemoglobinemia: A morbid condition due to the presence of sulfmethemoglobin in the blood. It is marked by persistent cyanosis, but the blood count does not reveal any special abnormality in the blood. It is thought to be caused by the action of hydrogen sulfide absorbed from the intestine. (Stedman, 25th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kushakovskiĭ, MS | 1 |
1 other study available for quinacrine and Sulfhemoglobinemia
| Article | Year |
|---|---|
[Acute drug-induced hemolytic anemia associated with met- and sulfhemoglobinemia (glucose-6-phosphate dehydrogenase deficiency in the erythrocytes)].
Topics: Adult; Benzocaine; Female; Glucosephosphate Dehydrogenase Deficiency; Humans; Methemoglobinemia; Qui | 1966 |